Comparative Effectiveness of Bivalent (Original/Omicron BA.4/BA.5) COVID-19 Vaccines in Adults

The emergence of Omicron variants coincided with declining vaccine-induced protection against SARS-CoV-2. Two bivalent mRNA vaccines, mRNA-1273.222 (Moderna) and BNT162b2 Bivalent (Pfizer-BioNTech), were developed to provide greater protection against the predominate circulating variants by includin...

Descripción completa

Detalles Bibliográficos
Autores principales: Kopel, Hagit, Nguyen, Van Hung, Boileau, Catherine, Bogdanov, Alina, Winer, Isabelle, Ducruet, Thierry, Zeng, Ni, Bonafede, Mac, Esposito, Daina B., Martin, David, Rosen, Andrew, Van de Velde, Nicolas, Vermund, Sten H., Gravenstein, Stefan, Mansi, James A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675676/
https://www.ncbi.nlm.nih.gov/pubmed/38006043
http://dx.doi.org/10.3390/vaccines11111711

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675676/
https://www.ncbi.nlm.nih.gov/pubmed/38006043
http://dx.doi.org/10.3390/vaccines11111711

Ejemplares similares